	US 12,459,905 B2
	Reagent for mass spectrometry
Dieter Heindl, Munich (DE); Hans-Peter Josel, Weilheim (DE); Uwe Kobold, Weilheim (DE); Christoph Seidel, Weilheim (DE); Martin Rempt, Penzberg (DE); Andreas Leinenbach, Oberhausen (DE); Giuseppe Prencipe, Penzberg (DE); Silvia Baecher, Munich (DE); Simon Ferdinand Loibl, Wolfratshausen (DE); Anna-Skrollan Geiermann, Munich (DE); Jelena Milic, Penzberg (DE); Robert Hahn, Munich (DE); and Nicole Pirkl, Penzberg (DE)
Assigned to Roche Diagnostics Operations, Inc., Indianapolis, IN (US)
Filed by Roche Diagnostics Operations, Inc., Indianapolis, IN (US)
Filed on Jan. 21, 2021, as Appl. No. 17/154,501.
Application 17/154,501 is a continuation of application No. PCT/EP2019/069729, filed on Jul. 23, 2019.
Claims priority of application No. 18185354 (EP), filed on Jul. 24, 2018.
Prior Publication US 2021/0188788 A1, Jun. 24, 2021
Int. Cl. C07D 257/04 (2006.01); C07D 249/06 (2006.01); H01J 49/00 (2006.01)

CPC C07D 257/04 (2013.01) [C07D 249/06 (2013.01); H01J 49/0031 (2013.01)]

5 Claims

1. A compound of formula A selected from the group consisting of